Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119137084 | 11913708 | 4 | F | 2011 | 20160706 | 20160113 | 20160713 | PER | US-PFIZER INC-2016005382 | PFIZER | 47.00 | YR | F | Y | 77.11000 | KG | 20160713 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119137084 | 11913708 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 2X/DAY | Y | 21446 | 50 | MG | BID | ||||||
119137084 | 11913708 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 1X/DAY | Y | 21446 | 50 | MG | QD | ||||||
119137084 | 11913708 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 75 MG, 2X/DAY | Y | M22778 | 21446 | 75 | MG | BID | |||||
119137084 | 11913708 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 50 MG, 1X/DAY | Y | 21446 | 50 | MG | QD | ||||||
119137084 | 11913708 | 5 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | U | 20235 | ||||||||||
119137084 | 11913708 | 6 | SS | NEURONTIN | GABAPENTIN | 1 | UNK | U | 20235 | ||||||||||
119137084 | 11913708 | 7 | C | METHOTREXATE. | METHOTREXATE | 1 | 8 TABLETS ONCE A WEEK | 0 | 8 | DF | TABLET | /wk | |||||||
119137084 | 11913708 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | 6 TABLETS ONCE A WEEK | 0 | 6 | DF | TABLET | /wk | |||||||
119137084 | 11913708 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 1 MG, 1X/DAY | 0 | 1 | MG | TABLET | QD | ||||||
119137084 | 11913708 | 10 | C | DEPAKOTE | DIVALPROEX SODIUM | 1 | Oral | 500 MG, 1X/DAY | 0 | 500 | MG | TABLET | QD | ||||||
119137084 | 11913708 | 11 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | Oral | 300 MG, 1X/DAY | 0 | 300 | MG | TABLET | QD | ||||||
119137084 | 11913708 | 12 | C | BUTALBITAL AND ACETAMINOPHEN | ACETAMINOPHENBUTALBITAL | 1 | Oral | 1000 MG, AS NEEDED (EVERY 4-6 HOURS) | 0 | 1000 | MG | TABLET | |||||||
119137084 | 11913708 | 13 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
119137084 | 11913708 | 1 | Neuropathy peripheral |
119137084 | 11913708 | 2 | Rheumatoid arthritis |
119137084 | 11913708 | 5 | Neuropathy peripheral |
119137084 | 11913708 | 6 | Rheumatoid arthritis |
119137084 | 11913708 | 7 | Rheumatoid arthritis |
119137084 | 11913708 | 9 | Supplementation therapy |
119137084 | 11913708 | 10 | Bipolar disorder |
119137084 | 11913708 | 11 | Depression |
119137084 | 11913708 | 12 | Pain |
119137084 | 11913708 | 13 | Vertigo |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
119137084 | 11913708 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
119137084 | 11913708 | Product use issue | |
119137084 | 11913708 | Suicidal ideation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
119137084 | 11913708 | 1 | 201306 | 201410 | 0 | |
119137084 | 11913708 | 2 | 201410 | 0 | ||
119137084 | 11913708 | 3 | 20160311 | 0 | ||
119137084 | 11913708 | 5 | 2011 | 2013 | 0 | |
119137084 | 11913708 | 6 | 201301 | 0 | ||
119137084 | 11913708 | 7 | 2012 | 0 | ||
119137084 | 11913708 | 8 | 201410 | 0 | ||
119137084 | 11913708 | 9 | 2012 | 201410 | 0 | |
119137084 | 11913708 | 10 | 2010 | 20160301 | 0 | |
119137084 | 11913708 | 11 | 2010 | 201506 | 0 | |
119137084 | 11913708 | 12 | 2011 | 201410 | 0 | |
119137084 | 11913708 | 13 | 2014 | 201410 | 0 |